The eight main blood types are A+, A-, B+, B-, O+, O-, AB+, and AB-. The most common blood type in the United States is O-positive, with around 38 percent of the population having this type of blood. However, blood type O-positive is more common in Latino-Americans than other ethnicities, with around 53 percent of Latino-Americans with this blood type, compared to 47 percent of African Americans and 37 percent of Caucasians. Blood donation The American Red Cross estimates that every two seconds someone in the United States needs blood or platelets, highlighting the importance of blood donation. It was estimated that in 2021, around 6.5 million people in the U.S. donated blood, with around 1.7 million of these people donating for the first time. Those with blood type O-negative are universal blood donors, meaning their blood can be transfused for any blood type. Therefore, this blood type is the most requested by hospitals. However, only about seven percent of the U.S. population has this blood type. Blood transfusion Blood transfusion is a routine procedure that involves adding donated blood to a patient’s body. There are many reasons why a patient may need a blood transfusion, including surgery, cancer treatment, severe injury, or chronic illness. In 2021, there were around 10.76 million blood transfusions in the United States. Most blood transfusions in the United States occur in an inpatient medicine setting, while critical care accounts for the second highest number of transfusions.

Snapshot img

Blood-Grouping Reagents Market Size 2025-2029

The blood-grouping reagents market size is forecast to increase by USD 611.8 million, at a CAGR of 8.8% between 2024 and 2029.

The market is driven by the increasing prevalence of chronic disorders necessitating frequent blood transfusions. The rising incidence of diseases such as cancer and thalassemia, among others, fuels the demand for blood-grouping reagents. Moreover, advancements in diagnostic devices, including automation of blood grouping systems and point-of-care devices, are streamlining the blood-grouping process, enhancing accuracy, and reducing turnaround time. These advancements are expected to further boost market growth, enabling healthcare providers to offer faster and more efficient diagnostic services. However, the risks associated with blood transfusion, including transfusion reactions and disease transmission, pose significant challenges.
Ensuring the safety and efficacy of blood-grouping reagents is crucial to mitigating these risks and maintaining patient trust. Companies in this market must prioritize innovation and regulatory compliance to address these challenges and capitalize on the growing demand for blood-grouping reagents.

What will be the Size of the Blood-Grouping Reagents Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The market is characterized by its continuous evolution, driven by the need for enhanced pre-transfusion and post-transfusion safety in the transfusion medicine sector. Reagents play a crucial role in ensuring quality assurance during various stages of blood transfusion, from specimen collection to antibody identification and lot number tracking. Pre-transfusion testing in hospital laboratories relies on high-throughput screening using automated immunoassay analyzers and flow cytometry for rapid and accurate blood grouping. Reagents for ABO grouping and Rh typing are essential in this process, requiring strict regulatory compliance and shelf life management. Post-transfusion testing is equally important, with polyclonal antibodies and monoclonal antibodies used for antibody screening and identification.

Quality control measures, including expiration dates, lot numbers, and reagent stability, are essential to minimize adverse events and maintain transfusion safety. The market for blood grouping reagents also extends to emergency medicine and point-of-care testing (POCT), where microplate technology and rapid testing methods enable quick and accurate results. Specimen preparation and plasma antigens are critical components in the overall process, ensuring accurate and reliable testing outcomes. Clinical trials and ongoing research continue to unfold new applications for blood grouping reagents, including advances in antibody titers, rh typing, and regulatory compliance. The market's dynamic nature underscores the importance of continuous innovation and quality control in the transfusion medicine sector.

How is this Blood-Grouping Reagents Industry segmented?

The blood-grouping reagents industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Hospitals and blood banks
  Clinical laboratories
  Academic and research institutes


Technique

  PCR-based and microarray techniques
  Assay-based techniques
  Massively parallel sequencing techniques
  Serology


Product

  Anti-sera reagents
  Red blood cell reagents
  Blood bank saline
  Others


Test Type

  Blood Grouping & Phenotyping
  Antibody Screening
  Cross-matching Tests
  Coombs Tests
  Antigen Typing
  Antibody Identification


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  South America

    Argentina
    Brazil


  Middle East and Africa

    UAE


  Rest of World (ROW)

By End-user Insights

The hospitals and blood banks segment is estimated to witness significant growth during the forecast period.

The market is significantly driven by the hospitals and blood banks segment due to the high utilization of these reagents for ensuring blood transfusion safety and quality assurance. The increasing number of hospitalizations for cancer treatment, chronic conditions, and emergency cases such as road accidents necessitates the extensive use of blood-grouping reagents in hospitals and blood banks. In emergency departments, these reagents play a crucial role in diagnosis, triage, and determining the need for immediate therapy, which must be carried out within a limited timeframe. Blood-grouping reagents find extensive application in

The global blood type special centrifuge market is poised for significant growth, driven by increasing demand for accurate and efficient blood component separation in hospitals and blood banks. Technological advancements leading to higher-speed, more precise centrifuges with improved safety features are key drivers. The rising prevalence of blood-related disorders and the growing need for blood transfusions globally fuel market expansion. Furthermore, the increasing adoption of automation and sophisticated data management systems in blood banks is streamlining operations and improving efficiency, thereby boosting demand for advanced centrifuges. The market is segmented by application (hospital, blood center, other) and type (refrigerated, non-refrigerated). Hospitals currently hold the largest market share due to their high volume of blood processing needs. However, the blood center segment is expected to witness substantial growth fueled by increasing investment in infrastructure and technological upgrades within these facilities. The non-refrigerated segment is projected to grow at a faster rate due to its cost-effectiveness and ease of use, particularly in resource-constrained settings. Geographic expansion is another key aspect. North America and Europe currently dominate, but rapidly developing economies in Asia-Pacific, particularly China and India, present significant opportunities. Competitive landscape is characterized by established players like Meditech, Thomas Scientific, Grifols, and newer entrants, spurring innovation and enhancing product offerings. Challenges for market expansion include the high initial investment costs associated with advanced centrifuge systems and the stringent regulatory requirements surrounding medical devices. However, these challenges are being mitigated by technological advancements reducing costs and by manufacturers focusing on regulatory compliance. The forecast period (2025-2033) anticipates continued market expansion, driven by factors including increasing healthcare spending, growing awareness of blood safety, and the continuing development of innovative centrifugation technologies. This growth will be further propelled by the expansion of blood banks and hospitals, especially in emerging markets, and the growing focus on personalized medicine, necessitating more precise blood component separation techniques. The market is projected to witness a healthy CAGR, outpacing the general medical equipment market growth rate.

Snapshot img

US Blood Bank Refrigerators Market Size 2025-2029

The US blood bank refrigerators market size is forecast to increase by USD 158.2 million at a CAGR of 6.9% between 2024 and 2029.

The Blood Bank Refrigerators Market in the US is experiencing significant growth, driven by the rising number of road accidents and sports injuries, which necessitates an increased demand for safe and efficient blood storage solutions. The market is further growing by the availability of advanced software and hardware products that enhance the functionality and capacity of blood bank refrigerators. However, the high cost of these refrigerators poses a challenge for smaller healthcare facilities and community blood banks, potentially limiting their adoption.
Regulatory hurdles also impact the market, requiring strict adherence to standards for blood storage and transportation to ensure patient safety. Navigating these challenges while capitalizing on the growing demand for blood storage solutions will require strategic planning and innovative approaches from market participants. Companies that can offer cost-effective, compliant, and technologically advanced solutions are poised to seize opportunities in this dynamic market.

What will be the size of the US Blood Bank Refrigerators Market during the forecast period?

Request Free Sample

The US blood bank refrigerators market is characterized by a heightened focus on ensuring blood product safety and quality. With the increasing demand for efficient and cost-effective blood component distribution, blood banks prioritize optimization and innovation. Blood product expiration is a significant concern, necessitating advanced handling and labeling techniques to maintain traceability. Blood component separation and processing technologies have revolutionized the industry, enhancing sustainability and reducing waste. Blood bank logistics and transportation systems have become crucial for ensuring the timely delivery of blood components, while innovation continues to drive improvements in blood product handling and cost-effectiveness.
Blood component distribution networks strive for optimal efficiency and accuracy, with a growing emphasis on automation and real-time tracking. Blood bank sustainability remains a priority, with a focus on reducing energy consumption and minimizing environmental impact.

How is this market segmented?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Hospitals and diagnostic centers
  Stand-alone blood bank centers
  Others


Product

  Standard electric refrigerators
  Solar-powered refrigerators
  Ice-lined refrigerators


Type

  Common indoor blood bank refrigerators
  Transport blood bank refrigerators


Product Type

  Plasma refrigerators
  Whole blood refrigerators
  Platelet refrigerators
  Combination refrigerators and freezers
  Undercounter and compact refrigerators


Geography

  North America

    US

By End-user Insights

The hospitals and diagnostic centers segment is estimated to witness significant growth during the forecast period.

In the rapidly evolving healthcare landscape, blood banks play a crucial role in ensuring temperature-controlled storage and timely delivery of life-saving blood components. Hospitals, particularly large multi-specialty institutions and hospital groups, are at the forefront of this demand due to their extensive range of surgical procedures and treatments. These hospitals, which can be sponsored by governments or private entities, generate significant revenue and engage closely with various stakeholders, including suppliers, reimbursement authorities, and regulatory bodies. To maintain the highest standards of blood safety and regulatory compliance, these hospitals invest in advanced blood bank equipment, such as smart refrigerators, compact refrigerators, and plasma refrigerators.

These refrigeration systems employ predictive maintenance, remote monitoring, and temperature mapping to ensure temperature uniformity and accuracy. Cloud-based systems and data logging facilitate efficient blood bank management and inventory control. Medical device manufacturers prioritize energy efficiency and environmental compliance in their refrigeration systems, offering energy savings and contributing to the overall sustainability of hospital operations. Blood bank professionals, including technicians and nurses, rely on user-friendly interfaces and temperature control features to optimize their workflows. Blood bank services, including accreditation, logistics, and automation, are increasingly being integrated with advanced technologies like artificial intelligence (AI) and machine learning (ML) to enhance quality assurance and streamline operat